Alvotech and Advanz Pharma have inked a deal to expand their commercial partnership to cover three additional biosimilar ...

OneSource Specialty Pharma partners with Xbrane Biopharma for biosimilar manufacturing, aiming to strengthen global supply ...

Witnesses at the April 8 hearing told legislators biosimilars save patients and taxpayers money, that pharmacy benefit ...

Under the terms of the agreement, the parties will be jointly responsible for developing and manufacturing the biosimilar ...

Alvotech and Dr Reddy’s Laboratories announced today they have entered a collaboration agreement to co-develop, manufacture ...

Alvotech and UK-based Advanz Pharma sign agreement to commercialise three additional biosimilar candidates in Europe.

Alvotech is expanding its partnership with Advanz Pharma to commercialize new products in Europe, including a Kesimpta biosimilar drug for MS.

Regulatory ApprovalLucentis® biosimilar FYB201/Ranivisio® (ranibizumab) approved in Brazil 05.06.2025 / 06:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Press ...

Switching to Humira biosimilars saved Navitus clients more than $315 million in upfront costs in 2024 and resulted in a 60% ...

ABT sees a 21.6% jump in CGM sales and growing global diagnostics demand, while FX and macro pressure temper its outlook.

We have five products that will launch in the next 12-18 months. We recently launched Yesintek in the immunology space -- a ...

SteinCares will handle all regulatory filings, registrations and commercialization of Ranibizumab in Latin America, while ...